Literature DB >> 23353558

Measurement of tactile allodynia in a murine model of bacterial prostatitis.

Marsha L Quick1, Joseph D Done, Praveen Thumbikat.   

Abstract

Uropathogenic Escherichia coli (UPEC) are pathogens that play an important role in urinary tract infections and bacterial prostatitis. We have recently shown that UPEC have an important role in the initiation of chronic pelvic pain, a feature of Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS). Infection of the prostate by clinically relevant UPEC can initiate and establish chronic pain through mechanisms that may involve tissue damage and the initiation of mechanisms of autoimmunity. A challenge to understanding the pathogenesis of UPEC in the prostate is the relative inaccessibility of the prostate gland to manipulation. We utilized a previously described intraurethral infection method to deliver a clinical strain of UPEC into male mice thereby establishing an ascending infection of the prostate. Here, we describe our protocols for standardizing the bacterial inoculum as well as the procedure for catheterizing anesthetized male mice for instillation of bacteria. CP/CPPS is primarily characterized by the presence of tactile allodynia. Behavior testing was based on the concept of cutaneous hyperalgesia resulting from referred visceral pain. An irritable focus in visceral tissues reduces cutaneous pain thresholds allowing for an exaggerated response to normally non-painful stimuli (allodynia). Application of normal force to the skin result in abnormal responses that tend to increase with the intensity of the underlying visceral pain. We describe methodology in NOD/ShiLtJ mice that utilize von Frey fibers to quantify tactile allodynia over time in response to a single infection with UPEC bacteria.

Entities:  

Mesh:

Year:  2013        PMID: 23353558      PMCID: PMC3582676          DOI: 10.3791/50158

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

1.  A new model of visceral pain and referred hyperalgesia in the mouse.

Authors:  J M A Laird; L Martinez-Caro; E Garcia-Nicas; F Cervero
Journal:  Pain       Date:  2001-06       Impact factor: 6.961

2.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome.

Authors:  Anthony J Schaeffer
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

4.  Acute bacterial inflammation of the mouse prostate.

Authors:  Bayli J Boehm; Sara A Colopy; Travis J Jerde; Christopher J Loftus; Wade Bushman
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

5.  Viscero-visceral hyperalgesia: characterization in different clinical models.

Authors:  Maria Adele Giamberardino; Raffaele Costantini; Giannapia Affaitati; Alessandra Fabrizio; Domenico Lapenna; Emmanuele Tafuri; Andrea Mezzetti
Journal:  Pain       Date:  2010-07-16       Impact factor: 6.961

6.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP).

Authors:  V E Rivero; C Cailleau; M Depiante-Depaoli; C M Riera; C Carnaud
Journal:  J Autoimmun       Date:  1998-12       Impact factor: 7.094

9.  Experimental autoimmune prostatitis after neonatal thymectomy in the mouse.

Authors:  O Taguchi; A Kojima; Y Nishizuka
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

10.  Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice.

Authors:  Jennifer M A Laird; Veronika Souslova; John N Wood; Fernando Cervero
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

View more
  10 in total

1.  TRPV1 in experimental autoimmune prostatitis.

Authors:  Kenny Roman; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2019-10-01       Impact factor: 4.104

2.  Role of PAR2 in the Development of Lower Urinary Tract Dysfunction.

Authors:  Kenny Roman; Stephen F Murphy; Joseph D Done; Kevin E McKenna; Anthony J Schaeffer; Praveen Thumbikat
Journal:  J Urol       Date:  2016-02-06       Impact factor: 7.450

3.  Commensal bacterial modulation of the host immune response to ameliorate pain in a murine model of chronic prostatitis.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Joseph D Done; Marsha L Quick; Utkucan Acar; Praveen Thumbikat
Journal:  Pain       Date:  2017-08       Impact factor: 7.926

4.  Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.

Authors:  Jonathan F Anker; Anum F Naseem; Hanlin Mok; Anthony J Schaeffer; Sarki A Abdulkadir; Praveen Thumbikat
Journal:  Nat Commun       Date:  2018-04-23       Impact factor: 14.919

5.  IL-1β-primed mesenchymal stromal cells exert enhanced therapeutic effects to alleviate Chronic Prostatitis/Chronic Pelvic Pain Syndrome through systemic immunity.

Authors:  Hanchao Liu; Xinning Zhu; Xiaohui Cao; Ani Chi; Jian Dai; Zhenqing Wang; Chunhua Deng; Min Zhang
Journal:  Stem Cell Res Ther       Date:  2021-09-25       Impact factor: 6.832

6.  Ningmitai capsules have anti-inflammatory and pain-relieving effects in the chronic prostatitis/chronic pelvic pain syndrome mouse model through systemic immunity.

Authors:  Hanchao Liu; Zhenqing Wang; Qigen Xie; Ani Chi; Yanqing Li; Jian Dai; Min Zhang; Chunhua Deng; Guihua Liu
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

7.  Nociceptive and inflammatory mediator upregulation in a mouse model of chronic prostatitis.

Authors:  Erica S Schwartz; Amy Xie; Jun-Ho La; G F Gebhart
Journal:  Pain       Date:  2015-08       Impact factor: 7.926

8.  Neuronal/astrocytic expression of chemokine (C-C motif) ligand 2 is associated with monocyte/macrophage recruitment in male chronic pelvic pain.

Authors:  Zhiqiang Liu; Stephen F Murphy; Larry Wong; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

9.  Pain-related behaviors and abnormal cutaneous innervation in a murine model of classical Ehlers-Danlos syndrome.

Authors:  Delfien Syx; Rachel E Miller; Alia M Obeidat; Phuong B Tran; Robin Vroman; Zoë Malfait; Richard J Miller; Fransiska Malfait; Anne-Marie Malfait
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

10.  Development and validation of an animal model of prostate inflammation-induced chronic pelvic pain: evaluating from inflammation of the prostate to pain behavioral modifications.

Authors:  Feng Zeng; Hequn Chen; Jinrui Yang; Long Wang; Yu Cui; Xiao Guan; Zhao Wang; Jiping Niu; Xiongbing Zu; Lin Qi; Xiangyang Zhang; Zhengyan Tang; Longfei Liu
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.